FeesSafety
Pluang+

Solstice Advanced Materials agrees to settle lawsuits over its Metropolis uranium plant, focusing on community investments.

Market News
29 Sep 2026, 23:15 WIB
PRNewsWire
View Source
Neutral
Solstice Advanced Materials agrees to settle lawsuits over its Metropolis uranium plant, focusing on community investments.

Solstice Advanced Materials has reached an agreement in principle to settle all litigation related to its Metropolis Works uranium conversion plant. The settlement includes significant investments in programs to improve the lives of Metropolis residents and awaits formal approval from courts and stakeholders. Solstice denies any wrongdoing but chose to settle to avoid prolonged legal costs and distractions, expecting no major impact on its business. The settlement marks a key step in resolving lawsuits dating back to 2018 involving local residents, the city, and county alleging property damage and personal injury.

Solstice Advanced Materials' settlement agreement on Metropolis Works litigation is the focus here, with Pluang market data providing context. As of Sep 30, 2026 02:51 WIB, 17 of 38 Basic Materials-sector US stocks on Pluang rose while 21 fell. Notable movers include VALE at USD 13.29 with a 31% sell / 69% buy order split, MP at USD 45.47 with 13% sell / 87% buy, and SLI at USD 1.79 with a typical hold time of 21 days.

More News

Anteris reports positive 30-day results for Medium-size DurAVR heart valve in severe aortic stenosis patients

Anteris reports positive 30-day results for Medium-size DurAVR heart valve in severe aortic stenosis patients

Anteris Technologies announced favorable 30-day clinical outcomes for its Medium-size DurAVR Transcatheter Heart Valve (THV) in 22 patients with severe aortic stenosis. The valve showed excellent hemodynamics with low pressure gradients, large effect...

Market News
Bullish
3 hours ago
CT-guided PCI matches IVUS outcomes with faster procedures and less contrast, changing treatment plans in 70% of cases.

CT-guided PCI matches IVUS outcomes with faster procedures and less contrast, changing treatment plans in 70% of cases.

A landmark P4 randomized trial showed that CT-guided percutaneous coronary intervention (PCI) delivers clinical outcomes comparable to the gold-standard intravascular ultrasound (IVUS) at one year, while reducing procedure time by 27% and contrast us...

Market News
Bullish
4 hours ago
Bitcoin miners earned $1.215B in October, but daily revenue per unit dropped 17.5% in November.

Bitcoin miners earned $1.215B in October, but daily revenue per unit dropped 17.5% in November.

Bitcoin miners collectively earned $1.215 billion in October, marking the strongest month since November 2025, though still below November 2025's $1.26 billion. Despite this high monthly revenue, the daily revenue per unit of mining power (hashprice)...

Protocol Fundamentals
Neutral
5 hours ago
Bitcoin miners hit 11-month revenue high in October despite 17.5% drop in mining profitability.

Bitcoin miners hit 11-month revenue high in October despite 17.5% drop in mining profitability.

In October 2026, Bitcoin miners earned their highest monthly revenue since November 2025, totaling $1.215 billion, despite a 7.3% drop in Bitcoin's price and a 17.54% decline in mining profitability (hashprice). This paradox occurred because the Bitc...

Protocol Fundamentals
Neutral
5 hours ago
Amazon shares dip after earnings miss, but Jim Cramer advises buying on strong AWS growth and record margins.

Amazon shares dip after earnings miss, but Jim Cramer advises buying on strong AWS growth and record margins.

Amazon's stock fell after its Q3 earnings showed revenue and EPS slightly below estimates, and guidance for Q4 sales was also cautious. However, Jim Cramer recommends buying the stock, highlighting strong growth in Amazon Web Services (AWS), which po...

Company Fundamentals
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App